Global Medical REIT Inc. (GMRE)

8.8 -2.33%
Sep 30 close; Powered by Koyfin
Company’s profitability is improving
Buy analyst rating
Average analyst stock price above current stock price

None for now.


  1. GMRE profitability is improving. The YoY profit margin change was 71.60 percentage points. See GMRE profitability chart.
  2. GMRE average analyst rating is Buy. See GMRE analyst rating chart.
  3. GMRE average analyst price target ($14.25) is above its current price ($9.67). See GMRE price target chart.


None that we could think of.